Federal award (PURCHASE ORDER, fiscal year 2021)
Recipient: ZYMERON CORPORATION
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2022-04-11 to 2022-08-31
Current total value of award: $167495.16
Description: FY21 CBD SBIR PHASE I - BUNYAVIRUS RESEARCH DEVELOPING SMALL MOLECULE METAL CHELATE CAP-ENDO INHIBITORS AS BROAD-SPECTRUM ANTI-BUNYAVIRALS.